Optimizing Donor Selection Strategies to Enhance Manufacturing Consistency & Cellular Therapy Product Quality

• Evaluating how donor characteristics and collection variables influence starting material quality, manufacturing success rates, and final product consistency
• Assessing Moffitt Cancer Center’s approach to balancing donor availability, cellular attributes, and operational considerations across clinical and commercial programs
• Implementing cross-functional donor selection and manufacturing strategies to reduce process variability, improve scalability, and support more reliable patient outcomes

Speakers:

Albert Ribickas

Manager, Bloody & Marrow Transplant Laboratory, Clinical Trial & Commercial Product Handling Team

Moffitt Cancer Center